The new group is called the Partnership for the U.S. Life Science Ecosystem, or PULSE. The founding members include Merck, AbbVie, Amgen and Novartis.
In a news release, PULSE said the Federal Trade Commission’s new approach to antitrust enforcement could overturn decades of a “long-standing precedent” of encouraging “pro-innovation M&A.” It argues that mergers and acquisitions are necessary for the industry, citing data that it takes 10 to 15 years and $2.6 billion to develop a new drug.
“The U.S. life sciences ecosystem depends on mergers and acquisitions as well as other collaborations to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients,” the organization’s website says.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
